Prevalence of Liver Damage in Patients Under Antiretroviral Therapy at Gitwe District Hospital
Abstract
Background: The emergence of liver diseases as one of the major causes of death in people infected with HIV has paralleled the introduction of more effective antiretroviral therapies. More than 60% of the prescribed drugs are cleared in the liver, and hepatic injury is the most frequent cause of drug discontinuation in clinical trials. Thus, it is not surprising that all ART drugs have some risk of hepatotoxicity, which varies depending on the specific characteristics of the drugs. Measuring liver enzymes is the most common way of determining hepatotoxicity. HIV and antiretroviral medications both cause abnormalities in liver enzymes. Antiretroviral (ARV) medications harm liver cells either directly or through their active metabolites
Objective: The aim of this study was to determine the prevalence of liver damage in patients exposed to antiretroviral therapy at Gitwe District Hospital.
Materials and methods: Retrospective study was conducted in 212 HIV patients attending GITWE District Hospital, Southern province, Rwanda from 2023-2024. Patients under HAART with valid liver function test results for alanine aminotransferase (ALT), aspartate aminotransferase (AST) were included.
Results: Among 212 patients included in the study, from 2023 to 2024, 24(11.32%) presented mild, moderate, and severe liver damage. Very few severe cases 4(1.9%) were observed, Normal female and male represented high percentage among the patients: 116(54.5%) and 72(34.0%) respectively.
Conclusions: Mild and moderate liver damage were present in HIV patients; Severe liver damage were rare 4(1.9%) in all patients but many of the patients showed normal liver function. The effort made by health care providers in regular monitoring of hepatotoxicity among HIV-infected patients and advising patient to moderate alcohol consumption must be supported in order to avoid severe liver damage and other health complications.
Keywords: HIV, antiretroviral Therapy, liver enzyme elevation, Prevalence
Keywords:
HIV, antiretroviral Therapy, liver enzyme elevation, PrevalenceDOI
https://doi.org/10.22270/jddt.v15i8.7057References
1. Lucien, K. C. The effects of antiretroviral treatment on liver function enzymes among HIV-infected out patients attending the central hospital of Yaounde, Cameroon. African Journal of Clinical and Experimental Microbiology,2010; 11(3). https://doi.org/10.4314/ajcem.v11i3.57777
2. Abarca, J. C. Antiretroviral therapies for human immunodeficiency virus and liver disease: challenges and opportunities. Annals of Hepatology. Annals of Hepatology,2020; 121-122. https://doi.org/10.1016/j.aohep.2020.02.004 PMid:32138869
3. Chwiki, S. C.-A. Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: an ultrastructural perspective. Ultrastructural pathology,2017; 41(2), 186-195. https://doi.org/10.1080/01913123.2017.1282066 PMid:28277148 PMCid:PMC6077994
4. Kaspar, M. B. Mechanisms of liver disease in patients infected with HIV. BMJ open gastroenterology,2017; 000166. https://doi.org/10.1136/bmjgast-2017-000166 PMid:29119002 PMCid:PMC5663263
5. Anyanwu, C. F. Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult . Frontiers in Reproductive Health,2021;664080. https://doi.org/10.3389/frph.2021.664080 PMid:36303994 PMCid:PMC9580740
6. Biały, M. C. Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons. Viruses,2023; 2432. https://doi.org/10.3390/v15122432 PMid:38140673 PMCid:PMC10747352
7. Goodrich, N. R. Alcoholic Liver Disease in People with Hiv in Low-and Middle-Income Countries: Prevalence and Factors Associated with Severity of Hepatic Fibrosis. In The Liver Meeting 2023, S1575-S1576.
8. Chopra, S. &. The American journal of medicine,. Laboratory tests and diagnostic procedures in evaluation of liver disease,1985; 221-230. https://doi.org/10.1016/0002-9343(85)90013-0 PMid:2411132
9. Thapa, B. R. Liver function tests and their interpretation. The Indian Journal of Pediatrics,2007; 663-671. https://doi.org/10.1007/s12098-007-0118-7 PMid:17699976
10. Qin, F. J. Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV/HCV infection: an 11-year retrospective cohort study in Guangxi, China . BMJ open,2019; 9(4), e023140. https://doi.org/10.1136/bmjopen-2018-023140 PMid:30944128 PMCid:PMC6500098
11. Mohammed, O. A. (2022). Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: a systematic review and meta-analysis. BMC Infectious Diseases, 826. https://doi.org/10.1186/s12879-022-07838-w PMid:36352398 PMCid:PMC9647905
12. Mulu, W. G. Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia. Ethiopian journal of health science,2013; 23(3), 217-226. https://doi.org/10.4314/ejhs.v23i3.4
Published
Abstract Display: 395 
PDF Downloads: 283 PDF Downloads: 16 How to Cite
Issue
Section
Copyright (c) 2025 Ishimwe Alain Prudence , Tharcisse Gatembezi , Gratien Twagirumukiza , Nsabiyaremye Lauben , Jean Claude Tuyishime , Colette Mukamana , Rwandema Joseph , Philippe Hakizimana
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.